LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 166
Next
>>
>
1 to 25 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
MCF7	CP724714	10	uM	LJP5	72	hr	1209	2778	4203	0.6601	0.5857
MCF7	HG-5-113-01	3.33	uM	LJP5	72	hr	1209	1316	4203	0.3136	0.0480
MCF7	CP466722	3.33	uM	LJP5	72	hr	1209	3332	4203	0.7963	0.7620
MCF7	CP724714	3.33	uM	LJP5	72	hr	1209	3762	4203	0.8966	0.8829
MCF7	HG-5-113-01	0.12	uM	LJP5	72	hr	1209	3723	4203	0.8869	0.8705
MCF7	HG-5-113-01	1.11	uM	LJP5	72	hr	1209	1448	4203	0.3457	0.1064
MCF7	CP466722	0.12	uM	LJP5	72	hr	1209	4175	4203	0.9932	0.9920
MCF7	CP466722	1.11	uM	LJP5	72	hr	1209	3824	4203	0.9113	0.8991
MCF7	CP724714	0.04	uM	LJP5	72	hr	1209	3813	4203	0.9088	0.8972
MCF7	CP724714	1.11	uM	LJP5	72	hr	1209	3699	4203	0.8820	0.8656
MCF7	HG-5-113-01	0.04	uM	LJP5	72	hr	1209	3957	4203	0.9412	0.9334
MCF7	Seliciclib	0.04	uM	LJP5	72	hr	1209	4445	4203	1.0582	1.0640
MCF7	Seliciclib	0.37	uM	LJP5	72	hr	1209	3931	4203	0.9357	0.9273
MCF7	HG-5-113-01	0.37	uM	LJP5	72	hr	1209	2153	4203	0.5125	0.3779
MCF7	Seliciclib	1.11	uM	LJP5	72	hr	1209	3350	4203	0.7974	0.7628
MCF7	CP466722	0.04	uM	LJP5	72	hr	1209	4412	4203	1.0522	1.0586
MCF7	Seliciclib	0.12	uM	LJP5	72	hr	1209	4189	4203	0.9983	0.9990
MCF7	CP466722	0.37	uM	LJP5	72	hr	1209	4156	4203	0.9898	0.9893
MCF7	Seliciclib	3.33	uM	LJP5	72	hr	1209	3016	4203	0.7184	0.6637
MCF7	CP466722	10	uM	LJP5	72	hr	1209	1742	4203	0.4146	0.2244
MCF7	CP724714	0.12	uM	LJP5	72	hr	1209	3746	4203	0.8906	0.8736
MCF7	CP724714	0.37	uM	LJP5	72	hr	1209	3529	4203	0.8399	0.8145
MCF7	Seliciclib	10	uM	LJP5	72	hr	1209	1223	4203	0.2908	0.0047
MCF7	Neratinib	0.04	uM	LJP5	72	hr	1209	3690	4203	0.8761	0.8552
MCF7	HG-5-113-01	10	uM	LJP5	72	hr	1209	569	4203	0.1358	-0.3430

<
<<
Previous
Page 1 of 166
Next
>>
>
1 to 25 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)